Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mariano Malaguarnera

Showing results (1-10 of 101) with videos related to

Pageof 11
Sort By:
Current Opinion in Gastroenterology|February 16, 2012
Carnitine derivatives: clinical usefulnessMariano Malaguarnera
International Journal of Medical Sciences|March 31, 2007
Rasburicase represents a new tool for hyperuricemia in tumor lysis syndrome and in goutLisa Cammalleri, Mariano Malaguarnera
Internal and Emergency Medicine|September 11, 2008
Egg white injuryLisa Cammalleri, Prospera Bentivegna, Mariano Malaguarnera
Expert Review of Hematology|January 26, 2012
Rasburicase for the treatment of tumor lysis in hematological malignanciesGiulia Malaguarnera, Maria Giordano, Mariano Malaguarnera
Critical Reviews in Oncology/Hematology|July 31, 2007
Tumor lysis syndrome in elderlyVitalinda Pumo, Dorotea Sciacca, Mariano Malaguarnera
Nature Clinical Practice. Oncology|August 9, 2006
The management of tumor lysis syndromeElvira Rampello, Tiziana Fricia, Mariano Malaguarnera
Cancer Biotherapy & Radiopharmaceuticals|March 28, 2002
Malignant melanoma of nasal cavity: case report and review of the literatureMariano Malaguarnera, Maria Vinci, Giovanni Pistone
Critical Reviews in Oncology/Hematology|July 7, 2009
The role of immunity in elderly cancerLucia Malaguarnera, Erika Cristaldi, Mariano Malaguarnera
Current Opinion in Gastroenterology|February 23, 2023
Carnitine derivatives beyond fatigue: an updateMichele Malaguarnera, Vito Emanuele Catania, Mariano Malaguarnera
Critical Reviews in Oncology/Hematology|May 24, 2011
Non-melanoma skin cancers in elderly patientsRosario Emanuele Perrotta, Maria Giordano, Mariano Malaguarnera
Pageof 11

Showing results (1-10 of 101) with videos related to

Sort By:
Pageof 11
Current Opinion in Gastroenterology|February 16, 2012
Carnitine derivatives: clinical usefulnessMariano Malaguarnera
International Journal of Medical Sciences|March 31, 2007
Rasburicase represents a new tool for hyperuricemia in tumor lysis syndrome and in goutLisa Cammalleri, Mariano Malaguarnera
Internal and Emergency Medicine|September 11, 2008
Egg white injuryLisa Cammalleri, Prospera Bentivegna, Mariano Malaguarnera
Expert Review of Hematology|January 26, 2012
Rasburicase for the treatment of tumor lysis in hematological malignanciesGiulia Malaguarnera, Maria Giordano, Mariano Malaguarnera
Critical Reviews in Oncology/Hematology|July 31, 2007
Tumor lysis syndrome in elderlyVitalinda Pumo, Dorotea Sciacca, Mariano Malaguarnera
Nature Clinical Practice. Oncology|August 9, 2006
The management of tumor lysis syndromeElvira Rampello, Tiziana Fricia, Mariano Malaguarnera
Cancer Biotherapy & Radiopharmaceuticals|March 28, 2002
Malignant melanoma of nasal cavity: case report and review of the literatureMariano Malaguarnera, Maria Vinci, Giovanni Pistone
Critical Reviews in Oncology/Hematology|July 7, 2009
The role of immunity in elderly cancerLucia Malaguarnera, Erika Cristaldi, Mariano Malaguarnera
Current Opinion in Gastroenterology|February 23, 2023
Carnitine derivatives beyond fatigue: an updateMichele Malaguarnera, Vito Emanuele Catania, Mariano Malaguarnera
Critical Reviews in Oncology/Hematology|May 24, 2011
Non-melanoma skin cancers in elderly patientsRosario Emanuele Perrotta, Maria Giordano, Mariano Malaguarnera
Pageof 11